Oncolys BioPharma (4588.TSE) Q1 2026 Earnings

Feb 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-32
-25
-19
-12

Details

Expected EPS
N/A
Actual EPS
-15
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Oncolys BioPharma⁩ (⁦4588.TSE⁩) has reported earnings of ⁦-15⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts